`
`& Unirrep SIATESs PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`wwwispto.go'
`Adexanuiria, Mefein 22313-1450
`&
`. GRPART
` LIINGor
`P APPLICATION }
`NUMBER
`:
`37i{c} DATE
`i
`UNC
`‘
`FIL PEE REC'D ‘
`ATTYDOCEET.NO
`gTOT CLAIMS $ N33 CLAIMS
`TSAO. 185
`U3/29/2023
`1660
`3537.29 1O006/MAC
`id
`i
`CONFIRMATION NO. 2363
`REPLACEMENT FILING RECEIPT
`
`26111
`
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`loth Stoct RW
`
`ee ae
`tT i ee
`
` cE
`
`10th Floor
`WASHINGTON, OC 20005
`
`Date Mailed: 08/4 7/2023
`
`Receipt is acknowledged of ihis non-provisional utility patent application. The application will be taken up for
`examination in due course. Applicant will be notified as to the results of the examination. Any correspondence
`concerning the application must include the following identification information: the U.S. APPLICATION NUMBER,
`FILING DATE, NAME OF FIRST INVENTOR, and TITLE OF INVENTION. Fees transmitted by check or draft are
`subject to collection.
`
`Please verify the accuracy of the data presented on this receipt. If an error is noted on this Filing Receipt, please
`submit a written request for a correcied Filing Receipi, including a properly marked-up ADS showing the changes
`with strike-through for deletions and underlining for additions. Hf you received a “Notice to File Missing Parts” or
`other Notice requiring a response for this application, please submit any requesi for correction to this Filing Receipt
`with your reply to the Notice. When the USPTO processes the reply to the Notice, the USPTO will generate another
`Filing Receipt incorporating the requesied corrections provided that the requesi is grantabie.
`
`Inventor(s}
`
`Hidekazu Masaki, Saitama City, Saitama, JAPAN;
`Shigefum! KUMAGHI, Saitama City, Saitama, JAPAN:
`Ryo YONEHARA, Saitama City, Saitama, JAPAN:
`Yula MATSUMURA, Yokohama-shi, Kanagawa, JAPAN:
`Hibiki KAWANO, Ota-ku, Tokyo, JAPAN:
`Takuto TOJO, Wakayama-shi, Wakayama, JAPAN;
`Takuya MORIMOTO, Ota-ku, Tokyo, JAPAN,
`KeiHAGA, Minato-ku, Tokyo, JAPAN:
`Reiko TODAKA, Minato-ku, JAPAN:
`Akihito SAWADA, Minato-ku, Tokyo, JAPAN:
`Tomomi TAKANO, Towada-shi, Aomori, JAPAN:
`
`Applicant(s}
`
`EPSILON MOLECULAR ENGINEERING, ING., Saitama City, Saitama, JAPAN;
`THE KITASATO INSTITUTE, Minato-ku, Tokyo, JAPAN:
`Kao Corporation, Chuo-ku, Tokyo, JAPAN;
`Assignment For Published Patent Application
`EPSILON MOLECULAR ENGINEERING, INC., Saitama City, Saitama, JAPAN
`THE KITASATO INSTITUTE, Minato-ku, Tokyo, JAPAN
`Kao Corporation, Chuo-ku, Tokyo, JAPAN
`
`Power of Attorney: The patent practitioners associated with Customer Number 26711
`
`page 1 of 4
`
`

`

`Domestic Priory data as claimed by applicant
`This application is a 371 of POT/UP2021/G36446 10/01/2021
`
`Foreign Applications (You may be eligible to benefit from the Patent Prosecution Highway prograrn at the
`USPTO. Please see http:/Avww.uspto.goy for more information)
`JAPAN 2020-168078 10/02/2020 No Access Code Provided
`JAPAN 2020-1 85266 11/05/2020 No Access Code Provided
`JAPAN 2020-201212 12/03/2020 No Access Code Provided
`JAPAN 2021-085698 05/20/2021 No Access Code Provided
`JAPAN 2021-134972 08/19/2021 No Access Code Provided
`JAPAN 2021-150604 09/15/2021 No Access Code Provided
`
`Permission to Access Application via Priority Document Exchange: Yes
`
`Permission to Access Search Results: Yes
`
`Applicant may provide or rescind an authorization for access using Form PTO/SB/39 or Form PTO/SB/69 as
`appropriate.
`
`if Required, Foreign Filing License Granted: 03/09/2023
`
`The country code and number of your priority application, to be used for fillng abroad under the Paris Convention,
`is US 18/029,185
`
`Projected Publication Date: 11/16/2023
`
`Non-Publication Request: No
`
`Early Publication Request: No
`Title
`
`SARS-COV-2-BINDING PEPTIDE
`
`Preliminary Class
`
`Statement under 37 CFR 1.55 or 1.78 for AIA (First Inventor to File) Transition Applications: No
`
`PROTECTING YOUR INVENTION OUTSIDE THE UNITED STATES
`
`Since the rights granted by a U.S. patent extend only throughout the territory of the United States and have no
`effect in a foreign country, an inventor who wishes patent protection in another country must apply for a patent
`in @ specific country or in regional patent offices. Applicants may wish to consider the filing of an international
`application underthe Patent Cooperation Treaty (PCT). An international (PCT) application generally has the same
`effect as a regular national patent application in each PCT-member country. The PCT process simplifies the filing
`of patent applications on the same invention in member countries, bul does not resull in a grant of “an international
`patent” and does not eliminate the need of applicants to file acelitional documents anc fees in countries where patent
`protection is desired.
`
`Almost every country has its own patent law, and a person desiring a patent in a particular country must make an
`application for patent in that country in accordance withits particular laws. Since the laws of many countries differ
`in various respects from the patent law of the United States, applicants are advised to seek guidance from specific
`foreign countries fo ensure that patent righis are not lost prematurely.
`
`page 2 of 4
`
`

`

`Applicants also are advised thatin the case of inventions made in the United States, the Director of the USPTO must
`issue a license before applicants can apply for a patent in a foreign country. The filing of a U.S. patent application
`serves as a tequest for a foreign Ming license. The application's fling receipt contains further information and
`guidance as to the status of applicant's license for foreign filing.
`
`Applicants may wish toe consult the USPTO booklet, “General information Concerning Patents" (specifically, the
`section entitled "Treaties and Foreign Patents") for more information on timeframes and deadlines for fling foreign
`patent applications. The guide is available elther by contacting the USPTO Contact Center al 800-786-9199, or Ht
`can be viewed on the USPTO website at http:/Awww.uspio.gov/web/offices/pac/doc/general/index.himl.
`
`For information on preventing iheft of your intellectual property (patents, trademarks and copyrights), you may wish
`to consult the U.S. Government website, htto:/Avww.stopfakes.gov. Part of a Depariment of Commerce initiative,
`this website inclucies self-help “toolkiis" giving innovators guidance on nowto protect intellectual properiy in specific
`countries such as China, Korea and Mexica. For questions regarding patent enforcement issues, applicants may
`call the U.S. Government hotline at 1-866-999-HALT (4-866-999-4258).
`
`LICENSE FOR FOREIGN FILING UNDER
`
`Tile 35, United States Code, Section 184
`
`Title 37, Code of Federal Regulations, 5.11 & 5.75
`
`GRANTED
`
`if the phrase "IF REQUIRED, FOREIGN FILING
`The applicant has been granted a license under 35 U.S.C. 184,
`LICENSE GRANTED"followed by a date appears on this form. Such licenses are issued in all applications where
`the conditions for issuance of a license have been met, regardless of whether or nat a license may be required as
`set forth in 37 CFR 5.15. The scope and limitations of this license are sei forth in 37 CFR 5.15(a)} unless an earlier
`license has been issued under 37 OFR 5.1505). The license is sublect to revocation upon written notification. The
`date indicated is the effective date of the —icense, unless an earlier Rcense of similar scope has been granted under
`37 CFR 5.43 or 5.14.
`
`This license is to be retained by the Hcensee and may be used at any time onor alterthe effective date thereof unless
`itis revoked. This license is automatically transferred to any related applications(s) filed under 37 GFR 1.53(d}. This
`license is not retroactive.
`
`The grant of a license does not in any way lessen the responsibility of a licensee far the security of the subiect matter
`as imposed by any Government contract or the provisions of existing jaws relating to espionage and the national
`security or the export of technical data. Licensees should apprise themselves of current regulations especially with
`respect to certain countries, of other agencies, particularly the Office of Defense Trade Controls, Department of
`State (with respect to Arms, Munitions and Implements of War (22 CFR 121-128)}: the Bureau of Indusiry and
`Security, Depariment of Commerce (15 CFR paris 790-774); the Office of Foreign AssetsContral, Department of
`Treasury (31 CFR Parts 500+) and the Deparirnent of Energy.
`
`NOT GRANTED
`
`No license under 35 U.S.C. 184 has been granted at this time, if ihe phrase "IF REQUIRED, FOREIGN FILING
`LIGENSE GRANTED" DOES NOTappear onthis form. Applicant may stl petition for a license under 37 GFR 5.12,
`if a license is desired before the expiration of 6 months from the filing date of the application. #6 months has lapsed
`
`page 3 of 4
`
`

`

`from the filing date of this application and the licensee has not received anyindication of a secrecy order under 35
`U.S.C. 181, the licensee may foreign file the application pursuant io 397 CFR 5.15(b).
`
`SefectUSA
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location for
`business invesiment, innovation, and commercialization of new technologies. The U.S. offers tremendous resources
`and advaniages for those who invest and manufacture goods here. Through SelectUiSA, our nation works to
`promote and facilitate business invesiment. SelectUSA provides information assistance to the international investor
`community; serves as an ombudsmanfor existing and potential investors; advocates on behalf of US. cities, states,
`and regions competing for global investment; and counseis U.S. economic development organizations on investment
`attraction best practices. To learn more about why the United States is the best country in the world to develop
`technology, manufacture products, deliver services, and grow your business, visit httpAvww. SelectUSA. govorcall
`+1-202-482-6800.
`
`page 4 of 4
`
`